Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Obesity, kidney dysfunction and hypertension: mechanistic links
John E. Hall, Jussara M. do Carmo, Alexandre A. da Silva, et al.
Nature Reviews Nephrology (2019) Vol. 15, Iss. 6, pp. 367-385
Open Access | Times Cited: 489

Showing 26-50 of 489 citing articles:

Pro-Inflammatory Profile of Adipokines in Obesity Contributes to Pathogenesis, Nutritional Disorders, and Cardiovascular Risk in Chronic Kidney Disease
Sylwia Czaja-Stolc, Marta Potrykus, Marta Stankiewicz, et al.
Nutrients (2022) Vol. 14, Iss. 7, pp. 1457-1457
Open Access | Times Cited: 46
The Association of Excess Body Weight with Risk of ESKD Is Mediated Through Insulin Resistance, Hypertension, and Hyperuricemia
Josef Fritz, Wolfgang Brozek, Hans Concin, et al.
Journal of the American Society of Nephrology (2022) Vol. 33, Iss. 7, pp. 1377-1389
Open Access | Times Cited: 41
Association of metabolic syndrome and chronic kidney disease
Florian G. Scurt, Maximilian J. Ganz, Carolin Herzog, et al.
Obesity Reviews (2023) Vol. 25, Iss. 1
Open Access | Times Cited: 36
Endothelial dysfunction, platelet hyperactivity, hypertension, and the metabolic syndrome: molecular insights and combating strategies
Diptimayee Das, N. R. Shruthi, Antara Banerjee, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 31
Mechanisms and treatment of obesity-related hypertension—Part 1: Mechanisms
Aneliya Parvanova, Elia Reseghetti, Manuela Abbate, et al.
Clinical Kidney Journal (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 25
Plant-food-derived Bioactives in Managing Hypertension: From Current Findings to Upcoming Effective Pharmacotherapies
Monica Butnariu, Deborah Fratantonio, Jesús Herrera‐Bravo, et al.
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 8, pp. 589-617
Closed Access | Times Cited: 23
Age, ethnic, and sex disparity in body mass index and waist circumference: a bi-national large-scale study in South Korea and the United States
Seounghyun Eum, Sang Youl Rhee
Life Cycle (2023) Vol. 3
Open Access | Times Cited: 23
Glomerular hyperfiltration as a therapeutic target for CKD
Mehmet Kanbay, Sidar Çöpür, Çiçek Nur Bakır, et al.
Nephrology Dialysis Transplantation (2024) Vol. 39, Iss. 8, pp. 1228-1238
Closed Access | Times Cited: 14
Salt-Sensitive Hypertension and the Kidney
Mitsuhiro Nishimoto, Karen A. Griffin, Brandi M. Wynne, et al.
Hypertension (2024) Vol. 81, Iss. 6, pp. 1206-1217
Closed Access | Times Cited: 14
Association between a metabolic score for insulin resistance and hypertension: results from National Health and Nutrition Examination Survey 2007–2016 analyses
Jing Zeng, Tingting Zhang, Yan Yang, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 11
Obesity-and lipid-related indices as a risk factor of hypertension in mid-aged and elderly Chinese: a cross-sectional study
Jiaofeng Gui, Yuqing Li, Haiyang Liu, et al.
BMC Geriatrics (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 10
“Zero” Intrinsic Fluorescence Sensing‐Platforms Enable Ultrasensitive Whole Blood Diagnosis and In Vivo Imaging
Gangwei Jiang, Hong Liu, Guohui Deng, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 16
Closed Access | Times Cited: 8
The signaling pathways in obesity‐related complications
Preethi Chandrasekaran, Ralf Weiskirchen
Journal of Cell Communication and Signaling (2024) Vol. 18, Iss. 2
Open Access | Times Cited: 8
Sarcopenia is not associated with hypertension, but sarcopenic obesity increases risk of hypertension: a 7-year cohort study
R. Du, Junchao Yuan, Yunda Huang, et al.
Frontiers in Public Health (2025) Vol. 12
Open Access | Times Cited: 1
Animal Models for Studying Developmental Origins of Cardiovascular–Kidney–Metabolic Syndrome
You‐Lin Tain, Ying-Jui Lin, Chien‐Ning Hsu
Biomedicines (2025) Vol. 13, Iss. 2, pp. 452-452
Open Access | Times Cited: 1
Cardiovascular diseases and metabolic abnormalities associated with obesity: What is the role of inflammatory responses? A systematic review
Nadia Hamjane, Fatiha Benyahya, Naima Ghailani Nourouti, et al.
Microvascular Research (2020) Vol. 131, pp. 104023-104023
Closed Access | Times Cited: 60
A review on protective role of genistein against oxidative stress in diabetes and related complications
Lihong Weng, Fengying Zhang, Rui Wang, et al.
Chemico-Biological Interactions (2019) Vol. 310, pp. 108665-108665
Closed Access | Times Cited: 58
Perirenal Adipose Tissue—Current Knowledge and Future Opportunities
Adriana Grigoraş, Raluca Bălan, Irina-Draga Căruntu, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 6, pp. 1291-1291
Open Access | Times Cited: 51
Prevalence and lifestyle-related risk factors of obesity and unrecognized hypertension among bus drivers in Ghana
Enoch Odame Anto, William K. B. A. Owiredu, Eric Adua, et al.
Heliyon (2020) Vol. 6, Iss. 1, pp. e03147-e03147
Open Access | Times Cited: 50
Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity: Comparison of Gastric Bypass, Sleeve Gastrectomy, and Usual Care
Ali Aminian, Rickesha Wilson, Alexander Zajichek, et al.
Diabetes Care (2021) Vol. 44, Iss. 11, pp. 2552-2563
Open Access | Times Cited: 50
Perirenal Adipose Tissue Inflammation: Novel Insights Linking Metabolic Dysfunction to Renal Diseases
Safaa H. Hammoud, Ibrahim AlZaim, Yusra Al-Dhaheri, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 49
The association of triglyceride and glucose index, and triglyceride to high‐density lipoprotein cholesterol ratio with prehypertension and hypertension in normoglycemic subjects: A large cross‐sectional population study
Fomin Zhang, Yingyi Zhang, Zhigang Guo, et al.
Journal of Clinical Hypertension (2021) Vol. 23, Iss. 7, pp. 1405-1412
Open Access | Times Cited: 48
Pro-angiogenic activity and vasculogenic mimicry in the tumor microenvironment by leptin in cancer
Ana K. Herrera-Vargas, Eduardo García-Rodríguez, Monserrat Olea‐Flores, et al.
Cytokine & Growth Factor Reviews (2021) Vol. 62, pp. 23-41
Closed Access | Times Cited: 47
SGLT2 Inhibition for Cardiovascular Diseases, Chronic Kidney Disease, and NAFLD
Moein Ala
Endocrinology (2021) Vol. 162, Iss. 12
Open Access | Times Cited: 46
Highlights of mechanisms and treatment of obesity-related hypertension
Elham Shams, Vijayvardhan Kamalumpundi, Joshua Peterson, et al.
Journal of Human Hypertension (2022) Vol. 36, Iss. 9, pp. 785-793
Closed Access | Times Cited: 32

Scroll to top